Sort
34,240 grants matching “atherosclerosis”
Novel pathways controlling macrophage inflammation and resolution in atherosclerosis
$720,981Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2022 · HL
Novel pathways controlling macrophage inflammation and resolution in atherosclerosis
$720,981Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2020 · HL
Regulation of Granulocyte and Macrophage Production
$720,975E Richard Stanley · Albert Einstein College Of Medicine · R37 · FY2009 · CA
Oral Infections and Vascular Disease Epidemiology Study (INVEST)
$720,791Moise Desvarieux · Columbia University Health Sciences · R01 · FY2013 · DE
EHD1-mediated Inflammation and Resolution in Atherosclerosis
$720,774Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT Collaboration
$720,705Nicholas L Smith · University Of Washington · R01 · FY2023 · HL
Focal Myocardial Delivery of Small Molecule Nitroalkenes using Ultrasound Targeted Microbubble Cavitation to Improve Ventricular Recovery Following Myocardial Infarction
$720,676John J Pacella · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Multiethnic machine learning brain signatures of ADRD
$720,673Mohamad Habes · University Of Texas Hlth Science Center · R01 · FY2022 · AG
Genetic Studies of The Impact of Hematologic Traits On Cardiovascular Disease
$720,655Santhi K Ganesh · University Of Michigan At Ann Arbor · R01 · FY2016 · HL
Engineering an Atherosclerosis-Resistant Endothelium
$720,544Martin A. Schwartz · University Of Virginia · R01 · FY2011 · HL
Thromboregulation in Occlusive Vascular Diseases
$720,525Aaron J. Marcus · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · HL
COPD cachexia: deciphering the impact of antioxidants, iron and mitochondrial function using 'omics approaches
$720,510Merry-Lynn Noelle McDonald Donnelly · University Of Alabama At Birmingham · R56 · FY2020 · HL
AZITHROMYCIN AND CORONARY ARTERY DISEASE
$720,510University Of Washington · U10 · FY2001 · HL
Small molecule therapies targeting chromatin architecture in heart failure
$720,487Thomas Martin Vondriska · University Of California Los Angeles · R01 · FY2022 · HL
Small molecule therapies targeting chromatin architecture in heart failure
$720,487Thomas Martin Vondriska · University Of California Los Angeles · R01 · FY2021 · HL
Small molecule therapies targeting chromatin architecture in heart failure
$720,487Thomas Martin Vondriska · University Of California Los Angeles · R01 · FY2023 · HL
Nitro-Fatty Acids and Cardiovascular Disease
$720,438Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2025 · HL
Nitro-Fatty Acids and Cardiovascular Disease
$720,438Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Nitro-Fatty Acids and Cardiovascular Disease
$720,438Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Integrating Artificial Intelligence for Optimal Analysis of CardiacPET/CT
$720,438Piotr J Slomka · Cedars-Sinai Medical Center · R01 · FY2023 · EB
Atheroprotective Gene Therapy
$720,435David A Dichek · University Of Washington · R01 · FY2022 · HL
Atheroprotective Gene Therapy
$720,435David A Dichek · University Of Washington · R01 · FY2020 · HL
Atheroprotective Gene Therapy
$720,435David A Dichek · University Of Washington · R01 · FY2021 · HL
Mechanism and inhibition of SREBP-dependent cholesterol/lipid metabolism
$720,423Gerhard Wagner · Harvard Medical School · R01 · FY2014 · HL
PAR 13-233 cART accelerates vascular aging in HIV infected subjects
$720,374Giovanni Schifitto · University Of Rochester · R01 · FY2018 · HL